Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6285983rdf:typepubmed:Citationlld:pubmed
pubmed-article:6285983lifeskim:mentionsumls-concept:C0033384lld:lifeskim
pubmed-article:6285983lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:6285983lifeskim:mentionsumls-concept:C1291208lld:lifeskim
pubmed-article:6285983pubmed:issue2lld:pubmed
pubmed-article:6285983pubmed:dateCreated1982-10-12lld:pubmed
pubmed-article:6285983pubmed:abstractText1. Treatment of prolyl 4-hydroxylase (prolyl-glycyl-peptide, 2-oxoglutarate:oxygen oxidoreductase (4-hydroxylating), EC 1.14.11.2) with 2-oxoglutarate in the absence of added Fe2+ for 10 s causes partial inactivation of the enzyme which is not reversed by subsequent addition of Fe2+. It appears that 2-oxoglutarate prevents loss of enzyme-bound iron and prevents access of added iron to its binding site. 2. For optimal enzyme activity the enzyme should be preincubated for 15 s with Fe2+ (5 microM). 3. Under turnover conditions prolyl 4-hydroxylase does not release iron. 4. The inactivation brought about by pre-incubation with 2-oxoglutarate and O2 in the absence of ascorbate is partly reversed by removal of 2-oxoglutarate. 5. It is proposed that dead-end complex formation with 2-oxoglutarate is responsible for the inactivation of the enzyme by 2-oxoglutarate in the absence of either ascorbate or Fe2+. 6. Optimal enzyme activity is obtained if the reactants are added to the reaction medium in the following order: enzyme, iron and ascorbate in any order, then after at least 15 s 2-oxoglutarate and finally (Pro-Pro-Gly)5 to start the reaction.lld:pubmed
pubmed-article:6285983pubmed:languageenglld:pubmed
pubmed-article:6285983pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6285983pubmed:citationSubsetIMlld:pubmed
pubmed-article:6285983pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6285983pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6285983pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6285983pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6285983pubmed:statusMEDLINElld:pubmed
pubmed-article:6285983pubmed:monthJunlld:pubmed
pubmed-article:6285983pubmed:issn0006-3002lld:pubmed
pubmed-article:6285983pubmed:authorpubmed-author:KempAAlld:pubmed
pubmed-article:6285983pubmed:authorpubmed-author:de JongLLlld:pubmed
pubmed-article:6285983pubmed:authorpubmed-author:NietfeldJ JJJlld:pubmed
pubmed-article:6285983pubmed:issnTypePrintlld:pubmed
pubmed-article:6285983pubmed:day4lld:pubmed
pubmed-article:6285983pubmed:volume704lld:pubmed
pubmed-article:6285983pubmed:ownerNLMlld:pubmed
pubmed-article:6285983pubmed:authorsCompleteYlld:pubmed
pubmed-article:6285983pubmed:pagination321-5lld:pubmed
pubmed-article:6285983pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:6285983pubmed:meshHeadingpubmed-meshheading:6285983-...lld:pubmed
pubmed-article:6285983pubmed:meshHeadingpubmed-meshheading:6285983-...lld:pubmed
pubmed-article:6285983pubmed:meshHeadingpubmed-meshheading:6285983-...lld:pubmed
pubmed-article:6285983pubmed:meshHeadingpubmed-meshheading:6285983-...lld:pubmed
pubmed-article:6285983pubmed:meshHeadingpubmed-meshheading:6285983-...lld:pubmed
pubmed-article:6285983pubmed:meshHeadingpubmed-meshheading:6285983-...lld:pubmed
pubmed-article:6285983pubmed:meshHeadingpubmed-meshheading:6285983-...lld:pubmed
pubmed-article:6285983pubmed:year1982lld:pubmed
pubmed-article:6285983pubmed:articleTitleThe influence of 2-oxoglutarate on the activity of prolyl 4-hydroxylase.lld:pubmed
pubmed-article:6285983pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6285983lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6285983lld:pubmed